SerraGold™
Enzymedica SerraGold™
SerraGold is a proteolytic enzyme blend
that contains Serratiopeptidase, or Serrapeptase, as it is sometimes called.
It represents one of the most potent enzyme formulas available in the
category. SerraGold has been formulated using the potent Serratiopeptidase
enzyme and Enzymedica's unique Protease Thera-blend and is intended for
those seeking the highest potency Serratiopeptidase available.
SerraGold™
Recommended Usage
Suggested Use: Take 1 capsule daily
before bed or upon rising. More may be taken as needed or recommended by a
health professional.
Store in a cool dry place. Keep out of
reach of children.
Serratiopeptidase:
Serratiopeptidase is a proteolytic enzyme originally discovered in the
digestive tract of the Japanese silk worm but is now derived almost
exclusively from bacteria of the genus Serratia strain. Serratiopeptidase
has proven to be effective in improving circulation, speeding tissue repair,
alleviating joint discomfort, supporting cardiovascular health, relieving
respiratory complaints and having anti-edema qualities.1-6
Serratiopeptidase has even been shown effective in transferring antibiotics
to the site of infection and is now widely used in Germany as an alternative
for many of these issues.7,8 It has such broad ranging effects
because of its possible mechanisms of action. There are three ways
Serratiopeptidase is believed to act, 1) through the elimination of
inflammatory mediators, 2) through the acceleration of liquefaction of pus
and sputum, and 3) through the enhancement of the action of antibiotics.9,10
Because Serratiopeptidase is an enzyme, specifically a protease, it has the
ability to survive the digestive tract and cross into the blood stream
remaining active.11
| Nutritional
Information |
Serving Size: 1
capsule
Capsules Per Container: 60 |
| Amount Per Capsule: |
Serratiopeptidase
Protease
TheraBlend
Mineral Blend |
100,000
SU
80,00 HUT
50 mg |
|
This product contain(s) no fillers. |
|
Protease TheraBlend.
Enzymedica's Protease Thera-blend has had long running success both
digestively and therapeutically. Protease given therapeutically may be
involved in many different types of healing in the body including the
digestion of protein pathogens, increasing circulation, eliminating waste
and supporting the immune system.
Mineral Blend. The mineral
blend found in SerraGold makes taking a high dose proteolytic formula easy
on the stomach. It consists of calcium / magnesium ratio of 2:1 along with
numerous trace minerals.
*These statements have not been evaluated
by the Food and Drug Administration. This product is not intended to
diagnose, treat, cure or prevent disease.
References:
1.) Anti-inflammatory oral enzyme Dr.
R.M. Bhansali, Head Dept of Orthopedics, K.E.M. Hospital Bomba. Seth Dhurmal
Bajaj Orthopedic Center
2.) Nieper, HA. Basic Cardiovascular Packet. Richland Center, Wisc: Brewer
Science Library
3.) Mazzonie, A. et al.. Evaluation of serrapeptase in acute or chronic
inflammation of otorhinolaryngology pathology: a multicentre, double-blind
randomized trial verses placebo. J. int. Med. Res. 1990. 18 (5), 379-388.
4.) Matsudo, A. et at. Effect of serrapeptase (Danzen) on inflammatory edema
following operation for thyropid disease. Med. Consult. New Remedy
18:171-175, 1981.
5.) A preliminary trial of serratiopeptidase in patients with carpel tunnel
syndrome.
J Assoc Physicians India. 1999 Sec; 47 (12): 1170-2; Comment in: J Assoc
Physicians India. 2000 Nov; 48(11) : 1130.Panagariya A. Sharma AK.Dept. of
Neurology, SMS Medical College and Hospital, Jaiper.
6.) Fujisaki S, Tomioka C, Uchida K. Preventative/therapeutic agent for
hepatitis B and C. Patent Abstracts of Japan JP11199509 A; July 27, 1999.
7.) Serratiopeptidase and Antibiotic Transferance Okumura et al 1977 ;
Ishihara 1983
8. )Aso T et al. Breast engorgement and it's treatment: Clinical effects of
Danzen an anti-inflammatory enzyme preparation.
The World of Obstetrics and Gynocology (Japanese). 1981:33:371-9.
9.) Mazzone A, et al. Evaluation of Serratia peptidase in acute or chronic
inflammation of otorhinolaryngology pathology: a multicentre, double-blind,
randomized trial versus placebo. J Int Med Res. 1990; 18(5):379-88.
10.) Role of Serratiopeptidase in Chronic Sinusitis Dept of E.N.T. Govt.
Medical College, Srinagar
11.) Intestinal absorption of serrapeptase (TSP) in rats. Moriya N, Nakata
M, Nakamura M, Takaoka M, Iwasa S Kato K, Kakinuma A. Biotechnology Research
Laboratories, Takeda Chemical Industries Ltd., Osaka, Japan.
|